ES2561813T3 - Aplicación tópica de nimesulida y tiocolchicósido - Google Patents

Aplicación tópica de nimesulida y tiocolchicósido Download PDF

Info

Publication number
ES2561813T3
ES2561813T3 ES10174934.9T ES10174934T ES2561813T3 ES 2561813 T3 ES2561813 T3 ES 2561813T3 ES 10174934 T ES10174934 T ES 10174934T ES 2561813 T3 ES2561813 T3 ES 2561813T3
Authority
ES
Spain
Prior art keywords
thiocolchicose
nimesulide
topical application
formulation
menthol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10174934.9T
Other languages
English (en)
Inventor
Fatih Cakir
Ali Turkyilmaz
Ümit Cifter
Levent Oner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Application granted granted Critical
Publication of ES2561813T3 publication Critical patent/ES2561813T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una formulación farmacéutica tópica que comprende nimesulida con tiocolchicósido, comprendiendo la formulación adicionalmente mentol.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
    imagen2
ES10174934.9T 2009-09-02 2010-09-01 Aplicación tópica de nimesulida y tiocolchicósido Active ES2561813T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2009/06775A TR200906775A1 (tr) 2009-09-02 2009-09-02 Nimesulid ve kas gevşetici kombinasyonları
TR200906775 2009-09-02

Publications (1)

Publication Number Publication Date
ES2561813T3 true ES2561813T3 (es) 2016-03-01

Family

ID=42077964

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10174934.9T Active ES2561813T3 (es) 2009-09-02 2010-09-01 Aplicación tópica de nimesulida y tiocolchicósido

Country Status (6)

Country Link
US (1) US20110053877A1 (es)
EP (1) EP2292218B1 (es)
ES (1) ES2561813T3 (es)
PL (1) PL2292218T3 (es)
SI (1) SI2292218T1 (es)
TR (1) TR200906775A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201103770A1 (tr) * 2011-04-19 2012-11-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Nimesulid ve metilsülfonilmetanin topikalfarmasötik bileşimleri.
US20140315843A1 (en) * 2011-12-16 2014-10-23 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Topical pharmaceutical compositions of thiocolchicoside and methylsulfonylmethane
US10959946B2 (en) 2014-03-14 2021-03-30 Azurity Pharmaceuticals, Inc. Composition and method for vancomycin oral liquid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725134B1 (fr) 1994-10-04 1996-12-20 Lederle Lab Nouvelle association pharmaceutique a base d'ibuprofene et de thiocolchicoside
US5837735A (en) * 1994-10-05 1998-11-17 Helsinn Healthcare S.A. Antiinflammatory agent for external use
FR2735369B1 (fr) 1995-06-13 1997-07-11 Synthelabo Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
IT1291278B1 (it) 1996-07-05 1999-01-07 Errekappa Euroterapici S P A Preparazione farmaceutica a base di nimesulide per uso topico
IT1289973B1 (it) * 1997-02-25 1998-10-19 Helsinn Healthcare Sa Sistemi gelificati di nimesulide per uso topico
US7105172B1 (en) * 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
ITBO20060313A1 (it) * 2006-04-26 2007-10-27 Alma Mater Studiorum Uni Di Bologna Formulazioni farmaceutiche per uso transdermico

Also Published As

Publication number Publication date
US20110053877A1 (en) 2011-03-03
TR200906775A1 (tr) 2011-03-21
SI2292218T1 (sl) 2016-03-31
PL2292218T3 (pl) 2016-05-31
EP2292218A2 (en) 2011-03-09
EP2292218B1 (en) 2015-11-11
EP2292218A3 (en) 2011-07-27

Similar Documents

Publication Publication Date Title
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2527242T3 (es) Composiciones que comprenden un germinante y un agente antimicrobiano
ES2637421T3 (es) Composiciones tópicas que comprenden variantes de pliegue-OB
CL2011000935A1 (es) Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor.
CL2012003281A1 (es) Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica.
CL2008000418A1 (es) Uso de un antagonista de la il-23 para el tratamiento de una infeccion fungica.
ES2620754T3 (es) Uso de 5-androstano (alquil)-3,5,6-triol en la preparación de fármacos neuroprotectores
CO7240372A2 (es) Formulaciones farmacéuticas tópicas no acuosas
NI201000172A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la hospitalización cardiovascular o de la mortalidad.
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
CL2013000801A1 (es) Composicion farmaceutica que comprende un inhibidor de rankl y una hormona o un derivado de la misma, y uso del inhibidor rankl para preparar dicha composicion
CL2008001024A1 (es) Compuestos derivados de ftalazinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades cardiovasculares, parkinson, enfermedades inflamatorias, esclerosis multiple, cancer, entre otras
AR082493A1 (es) Formulaciones a base de nalbufina, y sus utilizaciones
ES2525918T3 (es) Proceso para la fabricación de Nicorandil
ES2555778T3 (es) Mejora de la biodisponibilidad de principios activos con función amidina en medicamentos
CL2015002253A1 (es) Composiciones farmacéuticas para el tratamiento de la helicobacter pylori.
CY1121852T1 (el) Μορφοποιησεις και μεθοδοι παρασκευης μορφοποιησεων για χρηση στον καθαρισμο του παχεος εντερου
CL2008003006A1 (es) Uso de ester metilico del acido (-)-(3ar,4s,7ar)-4-hidroxi-4-m-toliletinil-octahidro-indol-1-carboxilico en base libre o en forma de sal para el tratamiento, prevencion o retraso de la progresion de la disquinesia de parkinson asociada a l-dopa; uso de la composicion farmaceutica; uso de una composicion que ademas comprende l-dopa.
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
UY34931A (es) ?formulación compuesta para administración oral que comprende metformina y rosuvastatina?.
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
ES2561813T3 (es) Aplicación tópica de nimesulida y tiocolchicósido
CL2011000388A1 (es) Combinacion farmaceutica que comprende (6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol y un antiinflamatorio no esteroidal; forma de dosificacion; uso en el tratamiento de la osteoartritis y el dolor.
CL2008000965A1 (es) Composicion farmaceutica que comprende un agente antiinflamatorio no esteroideo y un analgesico opiaceo, y su uso para el tratamiento del dolor.
EA201071412A1 (ru) Дронедарон для предотвращения кардиоверсии